Brain Vessels Normally Undergo Cyclic Activation and Inactivation: Evidence from Tumor Necrosis Factor-α, Heme Oxygenase-1, and Manganese Superoxide Dismutase Immunostaining of Vessels and Perivascular Brain Cells

Studies of vascular biology during the past decade have identified an expanding list of agonists and antagonists that regulate local hemostasis, inflammation, and reactivity in blood vessels. Interactions at the blood-endothelial interface are intricate and complex and have been postulated to play a role in the initiation of stroke and the progression of brain injury during early hours of ischemia, particularly in conjunction with reperfusion injury (Hallenbeck, 1996). In the current study of normal and activated vessels in rat brain, immunoreactive tumor necrosis factor-alpha (TNF-α), heme oxygenase-1 (HO-1), and manganese superoxide dismutase (MnSOD) exhibit concentric perivascular rings involving vessel wall and surrounding parenchyma that appear to coincide with one another in serial sections. The ring patterns suggest periodic radial expansion of these molecules released through a process of cyclic activation and inactivation of brain vessel segments. In this process, the rings appear randomly scattered instead of affecting all vessels within a high power field (HPF) synchronously. The average number of vessels per HPF (mean ± SD) with perivascular cuffs of immunoreactive MnSOD increased from 51 ± 28 in Wistar, 72 ± 46 in Wistar-Kyoto, and 84 ± 30 in Sprague Dawley rats (no spontaneous strokes) to 184 ± 72 in spontaneously hypertensive stroke-prone rats (spontaneous strokes). Perivascular immunoreactive cuffs are also increased in spontaneously hypertensive rats by induction of cytokine expression by lipopolysaccharide (64 ± 15 vs. 131 ± 32 /HPF). The patterns of TNF-α, HO-1, and MnSOD in naïve animals are interpreted to indicate that focal hemostatic balance normally fluctuates in brain vessels and influences surrounding parenchymal cells. Perivascular immunoreactive cuffs representing this process are more frequent in animals with lipopolysaccharide-induced endothelial activation or genetic stroke proneness.

[1]  S. Zahler,et al.  Endothelial function and hemostasis , 2000, Zeitschrift für Kardiologie.

[2]  W. Aird,et al.  Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.

[3]  J. Hoidal,et al.  TNF-α and IL-1α induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. , 1999, American journal of physiology. Heart and circulatory physiology.

[4]  C. Epstein,et al.  Increased Oxidative Damage Is Correlated to Altered Mitochondrial Function in Heterozygous Manganese Superoxide Dismutase Knockout Mice* , 1998, The Journal of Biological Chemistry.

[5]  L. Noble,et al.  Induction of heme oxygenase-1 (HO-1) in the contused spinal cord of the rat , 1998, Brain Research.

[6]  T. Nagaraja,et al.  Intracellular acidification induced by passive and active transport of ammonium ions in astrocytes. , 1998, American journal of physiology. Cell physiology.

[7]  B. Ames,et al.  The free radical theory of aging matures. , 1998, Physiological reviews.

[8]  J. Hoidal,et al.  Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.

[9]  Manuel Buttini,et al.  Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram , 1997, British journal of pharmacology.

[10]  S. Tonegawa,et al.  Reduced stress defense in heme oxygenase 1-deficient cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Maines,et al.  Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. , 1997, European journal of biochemistry.

[12]  S. Shackford,et al.  Production of tumor necrosis factor-alpha and interleukin-1beta by human cerebral microvascular endothelium after percussive trauma. , 1997, The Journal of trauma.

[13]  C. Duyckaerts,et al.  Tumor necrosis factor-α, microglia and astrocytes in AIDS dementia complex , 1997, Acta Neuropathologica.

[14]  A. Sauter,et al.  Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat , 1996, Neuroscience.

[15]  J. Hallenbeck,et al.  Inflammatory reactions at the blood-endothelial interface in acute stroke. , 1996, Advances in neurology.

[16]  E. Wang,et al.  Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. , 1995, Biochimica et biophysica acta.

[17]  B. Dwyer,et al.  Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. , 1995, Brain research. Molecular brain research.

[18]  C. Saper,et al.  Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Erl,et al.  Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  P. Young,et al.  Tumor necrosis factor-alpha expression in ischemic neurons. , 1994, Stroke.

[21]  M. Cuzner,et al.  Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.

[22]  P. Borm,et al.  Cell and tissue responses to oxidative damage. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[23]  G. Feuerstein,et al.  Increased Release of Tumor Necrosis Factor‐α Into the Cerebrospinal Fluid and Peripheral Circulation of Aged Rats , 1993, Stroke.

[24]  T. Yue,et al.  Release of Proinflammatory and Prothrombotic Mediators in the Brain and Peripheral Circulation in Spontaneously Hypertensive and Normotensive Wistar‐Kyoto Rats , 1992, Stroke.

[25]  J. Eaton,et al.  Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.

[26]  D. Wallace Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.

[27]  A. Malik,et al.  Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. , 1992, The Journal of clinical investigation.

[28]  A. Jovicić,et al.  Circadian variations of platelet aggregability and fibrinolytic activity in patients with ischemic stroke. , 1991, Thrombosis research.

[29]  G. Feuerstein,et al.  Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke , 1991, Brain Research.

[30]  H. Gerlach,et al.  Endothelium and regulation of coagulation. , 1991, Diabetes care.

[31]  G. Labrecque,et al.  Biological rhythms in the physiology and pharmacology of blood coagulation. , 1991, Chronobiology international.

[32]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[33]  G. Feuerstein,et al.  Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats. , 1990, Circulatory shock.

[34]  W. Dougall,et al.  Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. , 1990, The Journal of biological chemistry.

[35]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[36]  A. Davison,et al.  Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? , 1990, Free radical biology & medicine.

[37]  M. Shin,et al.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Daniel B Hier,et al.  Morning increase in onset of ischemic stroke. , 1989, Stroke.

[39]  Sangkot Marzuki,et al.  MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.

[40]  P. Libby,et al.  Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. , 1989, Journal of immunology.

[41]  W. Chandler,et al.  Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). , 1989, Circulation.

[42]  D. Goeddel,et al.  Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism , 1988, Science.

[43]  B. Ames,et al.  Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Kochanek,et al.  Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. , 1988, Stroke.

[45]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[46]  H. Marver,et al.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Shwartzman STUDIES ON BACILLUS TYPHOSUS TOXIC SUBSTANCES : II. THE EFFECT OF SERA UPON THE FACTORS DETERMINING LOCAL SKIN REACTIVITY TO FILTRATES OF BACILLUS TYPHOSUS CULTURES. , 1929 .

[48]  G. Shwartzman STUDIES ON BACILLUS TYPHOSUS TOXIC SUBSTANCES , 1928, The Journal of experimental medicine.